Newomics is a biotech company that sells and develops innovative and integrative platforms for LC-MS. In particular, the award-winning multinozzle M3 emitter, with the MnESI ion source, enhances the ionization efficiency to achieve unprecedented sensitivity, throughput, and robustness.
Our proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS), and offers unprecedented robustness, sensitivity, specificity, and throughput for analyzing molecules from minute amounts of biospecimens such as blood and urine.
Our core technologies are built upon the multinozzle emitter array (MEA) technology, invented from the Lawrence Berkeley National Laboratory (Berkeley Lab), which has won the 2012 R&D 100 award.
Location: United States, California, Berkeley
Member count: 11-50
Total raised: $7.9M
Founded date: 2011
Investors 3
| Date | Name | Website |
| 26.01.2021 | LDV Partne... | ldvp.com |
| - | Berkeley C... | berkeleyca... |
| - | SVE Capita... | sve-capita... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 01.12.2020 | Series B | $7.9M | - | vcnewsdail... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 02.12.2020 | Daily fund... | WaveOne has raised $6.5M; Data... | - | Kristin Ka... | vator.tv/n... |
| 01.12.2020 | Newomics R... | Newomics Inc., a Berkeley, Cal... | USA | - | finsmes.co... |
| 01.12.2020 | Newomics S... | BERKELEY, CA, Newomics today... | - | - | vcnewsdail... |